Literature DB >> 3032309

Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytes.

C Bloy, D Blanchard, P Lambin, D Goossens, P Rouger, C Salmon, J P Cartron.   

Abstract

A human monoclonal anti-Rh(D) antibody produced by an Epstein-Barr virus (EBV)-transformed B-cell line (IgG1(lambda), clone H2D5D2) has been purified on protein A-Sepharose column and used for binding studies and immune precipitation of the blood group rhesus (Rh) antigens. Scatchard plot analyses show that the 125I-labeled antibody (iodo-gen procedure), binds to 1.09 X 10(5), 0.43 X 10(5), and 0.32 X 10(5) antigen sites on each D--/D--, R2R2 and R1R1 RBC, respectively, with an association constant of approximately 0.6 X 10(8) mol/L-1. Immune precipitation studies indicate also that the Rh(D) antigen of the Rh(D)-positive RBCs is carried by a 29 kd polypeptide as deduced from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). No material could be precipitated from Rh(D)-negative or Rhnull RBCs. These results indicate that the monoclonal and the polyclonal human anti-Rh(D) behave similarly. A sample (Blo., presumed genotype R2r or R0R2) showing an increased number of antigen sites (0.76 X 10(5)/cell) and a high binding constant (5.7 X 10(8) mol/L-1) was used, as well as D--/D-- RBCs, for further purification of the 29-kd component. Extraction by Triton X-100 (0.1% to 5%) of the immune complexes formed between the membrane-bound Rh(D) antigens and the monoclonal antibody as well as a direct quantitative estimate of the 29-kd component, suggest that the Rh(D) polypeptide is loosely bound to the skeleton, since less than or equal to 80% can be solubilized from the membrane. In similar conditions, glycophorin A showed a slight association with the Triton-insoluble residue, whereas glycophorin B was easily and completely extracted. In contrast, both the minor RBC sialoglycoproteins, glycophorin C and glycoprotein gamma, remained predominantly bound to the membrane skeleton. The purified Rh(D) polypeptide obtained from Blo. and D--/D-- RBCs by immunoprecipitation and preparative gel electrophoresis was homogenous as judged by SDS-PAGE. Amino acid composition indicated that the Rh(D) protein contained sulfhydryl groups which are essential for biological activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032309

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Bispecific anti-human red blood Rhesus-D antigen x anti Fc gamma RI targeted antibody-dependent cell-mediated cytotoxicity and phagocytosis by mononuclear leucocytes.

Authors:  E X Deramoudt; C Gilard; N Lepine; J M Alonso; J L Romet-Lemonne
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Isolation of proteins related to the Rh polypeptides from nonhuman erythrocytes.

Authors:  A M Saboori; B M Denker; P Agre
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Biochemical identification and characterization of the G antigen in the human blood group Rh.

Authors:  J Lirochon; C Doinel; P Rouger; D Goossens; C Salmon
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

4.  Polymorphism in the Mr 32,000 Rh protein purified from Rh(D)-positive and -negative erythrocytes.

Authors:  A M Saboori; B L Smith; P Agre
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system.

Authors:  E Kajii; F Umenishi; S Iwamoto; S Ikemoto
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

6.  Intricate combinatorial patterns of exon splicing generate multiple Rh-related isoforms in human erythroid cells.

Authors:  E Kajii; F Umenishi; T Omi; S Ikemoto
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

Review 7.  Biochemistry of the erythrocyte Rh polypeptides: a review.

Authors:  P Agre; B L Smith; S Hartel-Schenk
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.